Atlas Trials

Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC

Clinical trial NCT00173862 · COMPLETED

Trial details

NCT number
NCT00173862
Sponsor
National Taiwan University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Transitional Cell Carcinoma
Start date
2000-05-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.